Physiological effects of melatonin: Implications on human health

Biomedicine

Volumn 28, Issue 4, 2008, Pages 252-255

  Chakravarty, Shilpa ^a   Rizvi, Syed Ibrahim ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Bioactivity; Melatonin; Pineal gland

Indexed keywords

GLUTATHIONE; MANNITOL; MELATONIN; REACTIVE OXYGEN METABOLITE;

ABSENCE OF SIDE EFFECTS; ACUTE KIDNEY FAILURE; AGING; BONE DISEASE; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EPILEPSY; FEMALE INFERTILITY; FOOD INTAKE; GASTROINTESTINAL DISEASE; GONAD DYSFUNCTION; HEART ARRHYTHMIA; HEART INFARCTION SIZE; HEART PROTECTION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; LIPID PEROXIDATION; MALE INFERTILITY; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARACRINE SIGNALING; PINEAL BODY; PLEIOTROPY; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; THERMOREGULATION;

EID: 58349121068     PISSN: 09702067     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Karasek M and Winczyk K. Melatonin in humans. J Physiol Pharmacol 2006; 57: 19-39.
2. Reiter RJ, Melchiorri D, Sewerynek E, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18: 1-11.
3. Axelrod J. The pineal gland: a neurochemical transducer. Science 1974; 184: 1341-1348.
4. Hardeland R and Poeggeler B. Non-vertebrate melatonin. J Pineal Res 2003; 34: 233-241.
5. Karasek M. Melatonin, human aging and age-related diseases. Exp Gerontol 2004; 39: 1723-1729.
6. Harper DG, Stopa EG, McKee AC, et al. Differential circadian rhythm disturbances in men with Alzheimer's disease and frontotemporal degeneration. Arch Gen Psychiatry 2001; 58: 353-360.
7. Morera AL and Abreu P. Seasonality of psychopathology and circannual melatonin rhythm. J Pineal Res 2006; 41: 279-283.
8. García JJ, Reiter RJ, Guerrero JM, et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS letters 1997; 408: 297-300.
9. Reiter RJ, Tan DX, Manchester LC and Tamura H. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J Physiol Pharmacol 2007; 58: 5-22.
10. Maestroni GJM and Conti A. Melatonin in relation to the immune system. In: Melatonin: Biosynthesis, physiological effect and clinical applications. Yu HS, Reiter RJ, editors. Boca Raton, FL: CRC Press. 1993: 289-311.
11. Schrader M, Danielsson C, Wiesenberg I and Carlberg C. Identification of natural monomeric response elements of the nuclear receptor RZR/ROR. They also bind COUP-TF homodimers. J Biol Chem 1996; 271: 19732-19736
12. Reiter RJ, Tan DX, Terron P, Flores LJ and Czarnocki Z. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions Acta Biochimica Polonica 2002; 54: 1-9.
13. 2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15: 2294-2296.
14. 1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 2003; 8: 205-213.
15. Carrillo-Vico A, Guerrero JM, Lardone PJ and Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200.
16. Skeidt SA. The Pineal gland and melatonin: Molecular and pharmacologic regulation. Annu Rev Pharmacol Toxicol 1999; 39: 53-65.
17. 2+concentration in chicken spleen leukocytes in vitro. J Pineal Res 2008; 44: 134-140.
18. Pandi-Perumal SR, Srinivasan V, Maestroni GJM, et al. Melatonin: Nature's most versatile biological signal? FEBS J 2006; 273: 2813-2838.
19. Konturek S J, Konturek P C and Brzozowski T. Role of melatonin in upper gastrointestinal tract. J Physiol Pharmacol 2007; 58: 23-52.
20. Konturek SJ, Brzozowski T, Konturek PC, Zwirska-Korczala K and Reiter RJ. Day/night differences in stress-induced gastric lesions in rats with an intact pineal gland or after pinealectomy. J Pineal Res. 2008; 44: 408-415.
21. Srinivasan V, Pandi-Perumal SR, Cardinali DP, Poeggeler B and Hardeland R. Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behav Brain Functions 2006; 2: 15.
22. Gupta M, Aneja S and Kohli K. Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial. Epilepsy Behav 2004; 5: 316-321.
23. Wang S, Thu L, Shi H, et al. Inhibition of melatonin biosynthesis induces neurofilament hyperphosphorylation with activation of cyclin-dependent kinase 5. Neurochem Res 2007; 32: 1329-1335.
24. Pacchierotti C, Iapichino S, Bossini L, Pieraccini F and Castrogiovanni P. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol 2001; 22: 18-32.
25. Sahna E, Türk G, Atessahin A, Yilmaz S and Olmez E. Remote organ injury induced by myocardial ischemia and reperfusion on reproductive organs, and protective effect of melatonin in male rats. Fertil Steril 2007; 88: 188-192.
26. Baker FC and Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Med 2007; 8: 613-622.
27. Savaskan E. Melatonin in aging and neurodegeneration. Drug Dev Res 2002; 56: 482-490.
28. El-Sokkary GH, Abdel-Rahman GH and Kamel ES. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 2005; 213: 25-33.
29. Labonia W, Rubio D and Arias C. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients. Nephrology 2005; 10: 583-587.
30. Sener G, Paskaloglu K, Toklu H, et al. Melatonin ameliorates chronic renal failure-induced oxidative organ damage in rats. J Pineal Res 2004; 36: 232-241.
31. Quiroz Y, Ferrebuz A, Romero F, Vaziri ND and Rodriguez-Iturbe B. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am J Physiol Renal Physiol 2008; 294: 336-344.
32. Karasek, Szuflet A, Chrzanowski W, Zylinska K and Swietoslawski J. Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett 2005; 26: 653-656.
33. Aydogdu N, Erbas H, Atmaca G, Erten O and Kaymak K. Melatonin reduces nitric oxide via increasing arginase rhabdomyolysis-induced acute renal failure in rats. Ren Failure 2006; 28: 435-440.
34. Sizonenko PC, Lang U, Rivest RW and Aubert ML. The pineal and pubertal development. Ciba Found Symp 1985; 117: 208-230.
35. Lee BM: Light exposure, melatonin secretion, and menstrual cycle parameters: an integrative review. Biol Res Nurs 2007; 9: 49-69.
36. Luboshitzky R, Lavi S, Thuma I and Lavie P. Increased nocturnal melatonin secretion in male patients with hypogonadotropic hypogonadism and delayed puberty. J Clin Endocrinol Metab 1995; 80: 2144-2148.
37. Hakanson DO, Bergstrom WH. Phototherapy-induced hypocalcemia in newborn rats: prevention by melatonin. Science 1981; 214: 807-809.
38. Grivas TB and Savvidou OD. Melatonin the "light of night" in human biology and adolescent idiopathic scoliosis. Scoliosis 2007; 2: 1-14.
39. Cardinali DP, Ladizesky MG, Boggio V, Cutrera RA and Mautalen C. Melatonin effects on bone: experimental facts and clinical perspectives. J Pineal Res 2003; 34: 81-87.
40. Cutando A, Gómez MG, Arana C, et al. Melatonin stimulates osteointegration of dental implants. J Pineal Res. 2008; 45: 174-179.
41. Hibaoui Y, Roulet E and Ruegg UT. Melatonin prevents oxidative-stress mediated mitochondrial permeability transition and death via enhancement of reduced pyridine nucleotides and glutathione in mouse skeletal muscle cells. Neuromusc Disord 2008; 18: 814:
42. Kedziora-Kornatowska K, Szewczyk-Golec K, Czuczejko J, et al. Effect of melatonin on the oxidative stress in erythrocytes of healthy young and elderly subjects. J Pineal Res 2007; 42: 153-158.
43. Reiter RJ. The ageing pineal gland and its physiological consequences. Bio Essays 1992; 14: 169-175.
44. Sharman EH, Sharman KG, Ge YW, Lahiri DK and Bondy SC. Age-related changes in murine CNS mRNA gene expression are modulated by dietary melatonin. J Pineal Res 2004; 41: 405-410.
45. Poeggeler B. Melatonin, aging, and age-related diseases: Perspectives for prevention, intervention and therapy. Endocrine 2005; 27: 201-212.
46. Altun A and Ugur-Altun B. Melatonin: Therapeutic and clinical utilization. Int J Clin Pract 2007; 61: 835-845.